Targeted drug delivery systems aim to deliver therapeutic agents like drugs or genes directly to the site of action in the body, thereby increasing their efficacy and reducing potential toxic effects. These systems help in precise targeting of drugs to organs, tissues or cells by encapsulating them within vehicles such as nanoparticles, liposomes, monoclonal antibodies etc. The growing demand for specialized therapies to treat cancer and other complex diseases has accelerated the development of advanced delivery mechanisms.
The global Targeted Drug Delivery Market is estimated to be valued at US$ 761.95 Mn in 2023 and is expected to exhibit a CAGR of 2.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising demand for specialized therapies is one of the key trends fueling the growth of the targeted drug delivery market. Advanced targeted delivery systems help in achieving higher drug concentrations at disease sites and reducing systemic toxicity effects by preventing early release of drugs in normal tissues. For cancer treatment, targeted drug delivery enhances bioavailability of anti-cancer drugs at tumor sites and their penetration into cancer cells. This enables delivery of lower drug doses for effective treatment while reducing side effects associated with chemotherapy. Rapid advances in nanotechnology have further accelerated the development of novel targeted drug carriers like polymeric nanoparticles, liposomes and antibody drug conjugates.
Segment Analysis
The global Targeted Drug Delivery market is segmented based on technology, product, indication and end-use. Based on technology, the market is further bifurcated into nanoparticles , liposomes, monoclonal antibodies, prodrug & drug conjugates and others. Among these, nanoparticle-based drug delivery systems dominates the market with over 30% share owing to benefits such as improving pharmacokinetics and bioavailability of drugs. Based on product, the market is categorized into nano-carriers, drug conjugates, polymeric nanoparticles, lipid-based drug delivery and others. Out of these, lipid-based drug delivery segment holds the largest share owing to biocompatible and biodegradable properties of lipids.
Key Takeaways
The global Targeted Drug Delivery Market Demand is expected to witness high growth during the forecast period of 2023 to 2030. The global Targeted Drug Delivery Market is estimated to be valued at US$ 761.95 Mn in 2023 and is expected to exhibit a CAGR of 2.1% over the forecast period 2023 to 2030.
Regional analysis: North America currently dominates the global Targeted Drug Delivery market with over 40% revenue share owing to favourable research funding and infrastructure. Asia Pacific is expected to grow at the fastest pace during the forecast period owing to rising geriatric population, improving healthcare infrastructure and increasing research in drug delivery systems in countries like China and India.
Key players: Key players operating in the Targeted Drug Delivery market are American Beryllia Inc., American Elements, Belmont Metals, Hunan Shuikoushan Nonferrous Metals Group Co. Ltd , IBC Advanced Alloys, Materion Corporation, and NGK Metals Corporation. Materion Corporation holds the largest market share of 15% globally owing to its strong product portfolio and global presence. IBC Advanced Alloys is also emerging as a prominent player in the market with its focus on technological innovations.
Explore more related article on this topic: https://www.newsanalyticspro.com/targeted-drug-delivery-market-demand/
Comments
0 comment